Literature DB >> 11299296

Phrenic long-term facilitation requires 5-HT receptor activation during but not following episodic hypoxia.

D D Fuller1, A G Zabka, T L Baker, G S Mitchell.   

Abstract

Episodic hypoxia evokes a sustained augmentation of respiratory motor output known as long-term facilitation (LTF). Phrenic LTF is prevented by pretreatment with the 5-hydroxytryptamine (5-HT) receptor antagonist ketanserin. We tested the hypothesis that 5-HT receptor activation is necessary for the induction but not maintenance of phrenic LTF. Peak integrated phrenic nerve activity (integralPhr) was monitored for 1 h after three 5-min episodes of isocapnic hypoxia (arterial PO(2) = 40 +/- 2 Torr; 5-min hyperoxic intervals) in four groups of anesthetized, vagotomized, paralyzed, and ventilated Sprague-Dawley rats [1) control (n = 11), 2) ketanserin pretreatment (2 mg/kg iv; n = 7), and ketanserin treatment 0 and 45 min after episodic hypoxia (n = 7 each)]. Ketanserin transiently decreased integralPhr, but it returned to baseline levels within 10 min. One hour after episodic hypoxia, integralPhr was significantly elevated from baseline in control and in the 0- and 45-min posthypoxia ketanserin groups. Conversely, ketanserin pretreatment abolished phrenic LTF. We conclude that 5-HT receptor activation is necessary to initiate (during hypoxia) but not maintain (following hypoxia) phrenic LTF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299296     DOI: 10.1152/jappl.2001.90.5.2001

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  105 in total

Review 1.  Breathing: rhythmicity, plasticity, chemosensitivity.

Authors:  Jack L Feldman; Gordon S Mitchell; Eugene E Nattie
Journal:  Annu Rev Neurosci       Date:  2003-02-13       Impact factor: 12.449

Review 2.  Respiratory modulation of premotor cardiac vagal neurons in the brainstem.

Authors:  Olga Dergacheva; Kathleen J Griffioen; Robert A Neff; David Mendelowitz
Journal:  Respir Physiol Neurobiol       Date:  2010-05-07       Impact factor: 1.931

Review 3.  Spinal plasticity following intermittent hypoxia: implications for spinal injury.

Authors:  Erica A Dale-Nagle; Michael S Hoffman; Peter M MacFarlane; Irawan Satriotomo; Mary Rachael Lovett-Barr; Stéphane Vinit; Gordon S Mitchell
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

4.  Severe acute intermittent hypoxia elicits phrenic long-term facilitation by a novel adenosine-dependent mechanism.

Authors:  Nicole L Nichols; Erica A Dale; Gordon S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2012-03-08

5.  Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.

Authors:  N L Nichols; R A Johnson; I Satriotomo; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2014-03-28       Impact factor: 1.931

6.  Tetraplegia is associated with enhanced peripheral chemoreflex sensitivity and ventilatory long-term facilitation.

Authors:  Abdulghani Sankari; Amy T Bascom; Anas Riehani; M Safwan Badr
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

7.  Hypoxia-induced hypotension elicits adenosine-dependent phrenic long-term facilitation after carotid denervation.

Authors:  Raphael R Perim; Paul S Kubilis; Yasin B Seven; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2020-07-29       Impact factor: 5.330

Review 8.  NADPH oxidase activity is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation.

Authors:  P M MacFarlane; I Satriotomo; J A Windelborn; G S Mitchell
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

9.  Adrenergic α₁ receptor activation is sufficient, but not necessary for phrenic long-term facilitation.

Authors:  A G Huxtable; P M MacFarlane; S Vinit; N L Nichols; E A Dale; G S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2014-02-13

10.  Determinants of frequency long-term facilitation following acute intermittent hypoxia in vagotomized rats.

Authors:  Tracy L Baker-Herman; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2008-03-18       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.